Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short-term Investments Total Current Liabilities Total Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

CorMedix (CRMD) Total Non-Current Liabilities (2016 - 2021)

CorMedix (CRMD) has disclosed Total Non-Current Liabilities for 6 consecutive years, with $6.0 million as the latest value for Q4 2021.

Quarterly Total Non-Current Liabilities changed N/A to $6.0 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $6.0 million through Dec 2021, changed N/A year-over-year, with the annual reading at $6.0 million for FY2021, N/A changed from the prior year.
Total Non-Current Liabilities hit $6.0 million in Q4 2021 for CorMedix, up from $3.9 million in the prior quarter.
In the past five years, Total Non-Current Liabilities ranged from a high of $6.0 million in Q4 2021 to a low of $3.9 million in Q2 2017.